AI Analysis
AI-generated analysis. Always verify with the original filing.
GSK plc disclosed initial notifications of transactions by PDMRs including Non-Executive Chair Sir Jonathan Symonds and Independent Non-Executive Directors, who purchased Ordinary Shares on London Stock Exchange (XLON) on 2026-03-18 and 2026-03-20, and American Depositary Shares (ADS) on New York Stock Exchange (XNYS) on 2026-03-20.
Key Takeaways
1Sir Jonathan Symonds (Non-Executive Chair) purchased 5,000 Ordinary Shares (ISIN GB00BN7SWP63) at aggregated price £19.5111 on 2026-03-20 (XLON)
2Wendy Becker (Independent Non-Executive Director) purchased 411 Ordinary Shares at £19.6250 on 2026-03-20 (XLON)
3Dr Gavin Screaton (Independent Non-Executive Director) purchased 6,335 Ordinary Shares at £19.6294 on 2026-03-18 (XLON)
4Charles Bancroft (Senior Independent Non-Executive Director) purchased 1,536 ADS (ISIN US37733W2044) at $51.7939 on 2026-03-20 (XNYS)
5Dr Vishal Sikka (Independent Non-Executive Director) purchased 797 ADS at $51.7939 on 2026-03-20 (XNYS)